Qube Research & Technologies (QRT)
GTBP icon

Qube Research & Technologies (QRT)’s GT Biopharma GTBP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– -$1 – 4628
2023
Q4 		– Hold
0
– – – 4274
2023
Q3 		– Hold
0
– – – 4182
2022
Q4 		– Sell
-20
Closed -$26K – 2675
2022
Q3 		$26K Hold
20
– – ﹤0.01% 2260
2022
Q2 		$46K Buy
+20
New +$37.9K ﹤0.01% 2140
2021
Q4 		– Sell
-19
Closed -$96K – 2696
2021
Q3 		$96K Buy
+19
New +$143K ﹤0.01% 1800

Other funds holding GTBP

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GTBP Position: Q1 2024 in Review

Qube Research & Technologies (QRT) held its GT Biopharma (GTBP) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4628.

Qube Research & Technologies (QRT) first reported a position in GTBP in Q3 2021 and has held it in 3 quarters since. The position peaked at $96K in Q3 2021. 11 funds tracked by Wall St. Rank hold GTBP as of Q1 2024.

  • Qube Research & Technologies (QRT) held 0 shares of GT Biopharma worth $0 as of Q1 2024.
  • Qube Research & Technologies (QRT) left its GT Biopharma share count unchanged in Q1 2024.
  • GT Biopharma made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2024, its #4628 holding.
  • Qube Research & Technologies (QRT) first reported a position in GT Biopharma in Q3 2021 and has held it in 3 quarters since.
  • Qube Research & Technologies (QRT)'s GT Biopharma position peaked at $96K in Q3 2021.
  • 11 funds tracked by Wall St. Rank held GT Biopharma as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.